Skip to main content
Erschienen in: Pediatric Cardiology 2/2008

01.03.2008 | Case Report

Cardiomyopathy in Multiple Acyl-CoA Dehydrogenase Deficiency

A Clinico-Pathological Correlation and Review of Literature

verfasst von: Mohit Singla, Grace Guzman, Andrew J. Griffin, Saroja Bharati

Erschienen in: Pediatric Cardiology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare autosomal recessive defect of the electron transfer flavoprotein or ubiquinone oxidoreductase, resulting in abnormal fatty acid, amino acid, and choline metabolism, leading to metabolic acidosis, hypoglycemia, “sweaty-feet” odor, and early neonatal deaths. This report presents a child diagnosed with this disease at birth by newborn screening using the mass spectrometer, who died suddenly at the age of 6 months. The echocardiogram revealed pericardial effusion, thickened ventricular musculature, and insufficiency of both the atrio-ventricular valves. The autopsy showed immense cardiomegaly, fatty infiltration, and hypertrophy of the ventricles. This is the first detailed case report of clinico-pathological correlation of MADD in an infant and brings into light a rare form of cardiomyopathy as a differential diagnosis in critically ill patients.
Literatur
1.
Zurück zum Zitat Al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT (2000) Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease. J Perinatol 20:120–128PubMedCrossRef Al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT (2000) Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease. J Perinatol 20:120–128PubMedCrossRef
2.
Zurück zum Zitat Bennett MJ, Curnock DA, Engel PC, Shaw L, Gray RG, Hull D, Patrick AD, Pollitt RJ (1984) Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally. J Inherit Metab Dis 7:57–61PubMedCrossRef Bennett MJ, Curnock DA, Engel PC, Shaw L, Gray RG, Hull D, Patrick AD, Pollitt RJ (1984) Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally. J Inherit Metab Dis 7:57–61PubMedCrossRef
3.
Zurück zum Zitat Bohm N, Uy J, Kiessling M, Lehnert W (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 139:60–65PubMedCrossRef Bohm N, Uy J, Kiessling M, Lehnert W (1982) Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 139:60–65PubMedCrossRef
4.
Zurück zum Zitat Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, Yoon H, Madsen JA, Reyes-Mugica M, Rinaldo P (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 132:924–933PubMedCrossRef Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, Yoon H, Madsen JA, Reyes-Mugica M, Rinaldo P (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 132:924–933PubMedCrossRef
5.
Zurück zum Zitat Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797–1817PubMedCrossRef Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797–1817PubMedCrossRef
6.
Zurück zum Zitat Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM (1988) Glutaric acidemia type II. Comparison of pathologic features in two infants. Arch Pathol Lab Med 112:1133–1139PubMed Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM (1988) Glutaric acidemia type II. Comparison of pathologic features in two infants. Arch Pathol Lab Med 112:1133–1139PubMed
7.
Zurück zum Zitat Domizio S, Romanelli A, Brindisino P, Puglielli C, Conte E, Domizio R, Sgarrella MC, Sabatino G (2005) Glutaric aciduria type II: a case report. Int J Immunopathol Pharmacol 18:805–808PubMed Domizio S, Romanelli A, Brindisino P, Puglielli C, Conte E, Domizio R, Sgarrella MC, Sabatino G (2005) Glutaric aciduria type II: a case report. Int J Immunopathol Pharmacol 18:805–808PubMed
8.
Zurück zum Zitat Galloway JH, Cartwright IJ, Bennett MJ (1987) Abnormal myocardial lipid composition in an infant with type II glutaric aciduria. J Lipid Res 28:279–284PubMed Galloway JH, Cartwright IJ, Bennett MJ (1987) Abnormal myocardial lipid composition in an infant with type II glutaric aciduria. J Lipid Res 28:279–284PubMed
9.
Zurück zum Zitat Goodman SI, McCabe ER, Fennessey PV, Mace JW (1980) Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res:14:12–17 Goodman SI, McCabe ER, Fennessey PV, Mace JW (1980) Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res:14:12–17
10.
Zurück zum Zitat Goodman SI, Stene DO, McCabe ER, Norenberg MD, Shikes RH, Stumpf DA, Blackburn GK (1982) Glutaric acidemia type II: clinical, biochemical, and morphologic considerations. J Pediatr 100:946–950PubMedCrossRef Goodman SI, Stene DO, McCabe ER, Norenberg MD, Shikes RH, Stumpf DA, Blackburn GK (1982) Glutaric acidemia type II: clinical, biochemical, and morphologic considerations. J Pediatr 100:946–950PubMedCrossRef
11.
Zurück zum Zitat Goodman SI, Reale M, Berlow S (1983) Glutaric acidemia type II: a form with deleterious intrauterine effects. J Pediatr 102:411–413PubMedCrossRef Goodman SI, Reale M, Berlow S (1983) Glutaric acidemia type II: a form with deleterious intrauterine effects. J Pediatr 102:411–413PubMedCrossRef
13.
Zurück zum Zitat Harkin JC, Gill WL, Shapira E (1986) Glutaric acidemia type II. Phenotypic findings and ultrastructural studies of brain and kidney. Arch Pathol Lab Med 110:399–401PubMed Harkin JC, Gill WL, Shapira E (1986) Glutaric acidemia type II. Phenotypic findings and ultrastructural studies of brain and kidney. Arch Pathol Lab Med 110:399–401PubMed
14.
Zurück zum Zitat Hockey A, Knowles S, Davies D, Carey W, Hurst J, Goldblatt J (1993) Glutaric aciduria type II, an unusual cause of prenatal polycystic kidneys: report of prenatal diagnosis and confirmation of autosomal recessive inheritance. Birth Defects Orig Article Ser 29:373–382 Hockey A, Knowles S, Davies D, Carey W, Hurst J, Goldblatt J (1993) Glutaric aciduria type II, an unusual cause of prenatal polycystic kidneys: report of prenatal diagnosis and confirmation of autosomal recessive inheritance. Birth Defects Orig Article Ser 29:373–382
15.
Zurück zum Zitat Kamiya M, Eimoto T, Kishimoto H, et al. (1990) Glutaric aciduria type II: autopsy study of a case with electron-transferring flavoprotein dehydrogenase deficiency. Pediatr Pathol 10:1007–1019PubMedCrossRef Kamiya M, Eimoto T, Kishimoto H, et al. (1990) Glutaric aciduria type II: autopsy study of a case with electron-transferring flavoprotein dehydrogenase deficiency. Pediatr Pathol 10:1007–1019PubMedCrossRef
16.
Zurück zum Zitat Medlock MD, Rhead WJ, Pollack L, Meredith JT, Pearl G, Reece C (1991) A case of glutaric acidemia type II (severe multiple acyl-CoA dehydrogenation disorder) with subsequent prenatal exclusion in a sibling. J Perinatol 11:227–230PubMed Medlock MD, Rhead WJ, Pollack L, Meredith JT, Pearl G, Reece C (1991) A case of glutaric acidemia type II (severe multiple acyl-CoA dehydrogenation disorder) with subsequent prenatal exclusion in a sibling. J Perinatol 11:227–230PubMed
17.
Zurück zum Zitat Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U (1983) Multiple acyl-CoA dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta 38:9–26PubMed Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U (1983) Multiple acyl-CoA dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta 38:9–26PubMed
18.
Zurück zum Zitat Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, Wadman SK (1976) Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 66:227–239PubMedCrossRef Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, Wadman SK (1976) Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 66:227–239PubMedCrossRef
19.
Zurück zum Zitat Slukvin II, Salamat MS, Chandra S (2002) Morphologic studies of the placenta and autopsy findings in neonatal-onset glutaric acidemia type II. Pediatr Dev Pathol 5:315–321PubMedCrossRef Slukvin II, Salamat MS, Chandra S (2002) Morphologic studies of the placenta and autopsy findings in neonatal-onset glutaric acidemia type II. Pediatr Dev Pathol 5:315–321PubMedCrossRef
20.
Zurück zum Zitat Sweetman L, Nyhan WL, Tauner DA, Merritt TA, Singh M (1980) Glutaric aciduria Type II. J Pediatr 96:1020–1026PubMedCrossRef Sweetman L, Nyhan WL, Tauner DA, Merritt TA, Singh M (1980) Glutaric aciduria Type II. J Pediatr 96:1020–1026PubMedCrossRef
21.
Zurück zum Zitat Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV (2003) d,l-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433–1435PubMedCrossRef Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV (2003) d,l-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433–1435PubMedCrossRef
22.
Zurück zum Zitat Wilson GN, de Chadarevian JP, Kaplan P, Loehr JP, Frerman FE, Goodman SI (1989) Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy. Am J Med Genet 32:395–401PubMedCrossRef Wilson GN, de Chadarevian JP, Kaplan P, Loehr JP, Frerman FE, Goodman SI (1989) Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy. Am J Med Genet 32:395–401PubMedCrossRef
Metadaten
Titel
Cardiomyopathy in Multiple Acyl-CoA Dehydrogenase Deficiency
A Clinico-Pathological Correlation and Review of Literature
verfasst von
Mohit Singla
Grace Guzman
Andrew J. Griffin
Saroja Bharati
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 2/2008
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-007-9119-6

Weitere Artikel der Ausgabe 2/2008

Pediatric Cardiology 2/2008 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.